Document ID: chunk:federal_register_of_legislation:F2020C00212:reg:9:p2
Version: federal_register_of_legislation:F2020C00212
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 9258–10069

PUVA treatment commenced at least five years before the clinical onset of malignant neoplasm of the eye; and
(ii)         at least 50 PUVA treatments were administered before the clinical onset of malignant neoplasm of the eye; or
                Note:      unprotected eye and whole body PUVA are defined in the Schedule 1 - Dictionary.
(b)          being treated with voriconazole for a continuous period of at least the two months before the clinical onset of malignant neoplasm of the eye;
(10)      for squamous cell carcinoma of the conjunctiva only, having an ocular prosthesis in an anophthalmic socket of the affected eye for more than ten years before the clinical onset of malignant neoplasm of the eye;
(11)      inability to obtain appropriate clinical management for malignant neoplasm of the eye.